Press Release

Vaccines Market Robust Expansion by Top Key Manufactures | Worldwide Overview by Size, Share, Trends, Segments

Vaccines Market: Global Industry Analysis by Top Manufacturers with Size, Share, Segments, Drivers and Challenges

The global vaccines market size is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% during the forecast period. The growing prevalence of malaria around the world is a key factor boosting the vaccines market. According to the World Health Organization, in 2017, there were an estimated 219 million cases of malaria in 87 countries. Total funding for malaria control and elimination reached an estimated US$ 3.1 billion in 2017. Contributions from governments of endemic countries amounted to US$ 900 million, representing 28% of total funding. Furthermore, the increasing number of deaths caused by malaria has impelled government and pharmaceutical companies to develop advanced vaccines. According to the latest world malaria report, released in November 2018, there were 219 million cases of malaria in 2017, up from 217 million cases in 2016. The estimated number of malaria death stood at 435 000 in 2017, a similar number to the previous year.

Request a Sample Copy of the Global Vaccines Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vaccines-market-101769

Global Vaccines Market Segmentation

By Type

  • Recombinant/Conjugate/Subunit
  • Inactivated
  • Live Attenuated
  • Toxoid

By Route of Administration

  • Parenteral
  • Oral

By Disease Indication

  • Viral Diseases
  • Bacterial Diseases

By Age Group

  • Pediatric
  • Adults

By Distribution Channel

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Some major points from Table of Content:

  1. Introduction

1.1.      Research Scope

1.2.      Market Segmentation

1.3.      Research Methodology

1.4.      Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.      Market Drivers

3.2.      Market Restraints

3.3.      Market Opportunities

  1. Key Insights

4.1.      New Product Launch

4.2.      Pipeline Analysis

4.3.      Technological Advancements in the Vaccines Market

4.4.      Prevalence of Disease Indications

4.5.      Key Industry Developments – Mergers, Acquisitions, and Partnerships

  1. Global Vaccines Market Analysis, Insights and Forecast, 2015-2026

5.1.      Key Findings / Summary

5.2.      Market Analysis, Insights and Forecast – By Type

5.2.1.   Recombinant/Conjugate/Subunit

5.2.2.   Inactivated

5.2.3.   Live Attenuated

5.2.4.   Toxoid

5.3.      Market Analysis, Insights and Forecast – By Route of Administration

5.3.1.   Parenteral

5.3.2.   Oral

5.4.      Market Analysis, Insights and Forecast – By Disease Indication

5.4.1.   Viral Diseases

5.4.2.   Bacterial Diseases

5.5.      Market Analysis, Insights and Forecast – By Age Group

5.5.1.   Pediatric

5.5.2.   Adults

5.6.      Market Analysis, Insights and Forecast – By Distribution Channel

5.6.1.   Hospital & Retail Pharmacies

5.6.2.   Government Suppliers

5.6.3.   Others

5.7.      Market Analysis, Insights and Forecast – By Geography

5.7.1.   North America

5.7.2.   Europe

5.7.3.   Asia pacific

5.7.4.   Latin America

5.7.5.   Middle East & Africa

  1. North America Vaccines Market Analysis, Insights and Forecast, 2015-2026

6.1.      Key Findings / Summary

6.2.      Market Analysis, Insights and Forecast – By Type

6.2.1.   Recombinant/Conjugate/Subunit

6.2.2.   Inactivated

6.2.3.   Live Attenuated

6.2.4.   Toxoid

6.3.      Market Analysis, Insights and Forecast – By Route of Administration

6.3.1.   Parenteral

6.3.2.   Oral

6.4.      Market Analysis, Insights and Forecast – By Disease Indication

6.4.1.   Viral Diseases

6.4.2.   Bacterial Diseases

6.5.      Market Analysis, Insights and Forecast – By Age Group

6.5.1.   Pediatric

6.5.2.   Adults

6.6.      Market Analysis, Insights and Forecast – By Distribution Channel

6.6.1.   Hospital & Retail Pharmacies

6.6.2.   Government Suppliers

6.6.3.   Others

6.7.      Market Analysis, Insights and Forecast – By Country

6.7.1.   U.S.

6.7.2.   Canada

  1. Europe Vaccines Market Analysis, Insights and Forecast, 2015-2026

7.1.      Key Findings / Summary

7.2.      Market Analysis, Insights and Forecast – By Type

7.2.1.   Recombinant/Conjugate/Subunit

7.2.2.   Inactivated

7.2.3.   Live Attenuated

7.2.4.   Toxoid

7.3.      Market Analysis, Insights and Forecast – By Route of Administration

7.3.1.   Parenteral

7.3.2.   Oral

7.4.      Market Analysis, Insights and Forecast – By Disease Indication

7.4.1.   Viral Diseases

7.4.2.   Bacterial Diseases

7.5.      Market Analysis, Insights and Forecast – By Age Group

7.5.1.   Pediatric

7.5.2.   Adults

7.6.      Market Analysis, Insights and Forecast – By Distribution Channel

7.6.1.   Hospital & Retail Pharmacies

7.6.2.   Government Suppliers

7.6.3.   Others

7.7.      Market Analysis, Insights and Forecast – By Country/Sub-region

7.7.1.   U.K.

7.7.2.   Germany

7.7.3.   France

7.7.4.   Spain

7.7.5.   Italy

7.7.6.   Scandinavia

7.7.7.   Rest of Europe

Continued…

KEY QUESTIONS ANSWERED:

What is the market size and growth rate of the global and regional market by various segments?

What is the market size and growth rate of the market for selective countries?

Which region or sub-segment is expected to drive the market in the forecast period?

What Factors are estimated to drive and restrain the market growth?

What are the key technological and market trends shaping the market?

What are the key opportunities in the market?

What are the key companies operating in the market?

Which company accounted for the highest market share?

Why Choose Fortune Business Insights?

 

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close